Biomarker Assessments of Leukine During Treatment of Parkinson's Disease
Safety, Tolerability and Biomarker Assessments of Leukine (Sargramostim) During Extended Timed Treatment for Parkinson's Disease: A Phase I Pilot Study Safety, Tolerability and Biomarker Assessments of Leukine (Sargramostim) During Extended Timed Treat ...
Sanofi;National Institute of Neurological Disorders and Stroke (NINDS);UNeMed;Nebraska Neuroscience Alliance Sanofi;National Institute of Neurological Disorders and Stroke (NINDS);UNeMed;Nebraska Neuroscience ...